Reshape's technology is used by companies to transition from chemical to bio-pesticides, test for seed germination rates, and perform ingredient characterization, among other uses. The platform makes results available to view in a cloud-based interface and supports data exports in formats such as LIMS or CSV. The company sells the full platform as a subscription, which includes the hardware, machine learning, and underlying software. With the new funding, Reshape plans to scale its business in the US, where it says around two-thirds of its revenue already comes from.
Key takeaways:
- Reshape, a Danish startup, has raised $20 million in a Series A funding round to expand its technology in the U.S. The company has developed a robotic imaging system with software and AI models to automate lab experiments that require visual inspections.
- The system allows experiments to be run 24/7 without direct supervision, freeing up technicians for other tasks. It also logs data to ensure experiments can be easily repeated.
- Reshape's technology is being used by companies to transition from chemical to bio-pesticides, test for seed germination rates, and perform ingredient characterization, among other things.
- The company sells the full platform as a subscription, which includes the hardware, machine learning and underlying software. It plans to use the new funding to scale its business in the U.S., where around two-thirds of its revenue already comes from.